Skip to content
Search

Latest Stories

NPA diversifies board with appointment of 3 Women

NPA diversifies board with appointment of 3 Women

The decision to appoint these women aligns with the NPA's new values-led approach, emphasising equality, inclusion, and diversity within its leadership structure.

In a move towards greater diversity and inclusivity, the National Pharmacy Association (NPA) has welcomed three accomplished women to its board of key members. Aisling O’Brien, Sukhi Basra, and Sehar Shahid-who is the youngest member- have joined the board, marking a significant step in the organisation's commitment to equality and representation.


The announcement, made on the occasion of the International Women’s Day, by chief executive, Paul Rees MBE via X reflects the organisation's dedication to celebrating and empowering women in the pharmacy profession.

Sukhi Basra, who joined the board as member since last April, adds a valuable dimension to the NPA. With her role as a Community Pharmacy KCW committee member and her experience in clinical pharmacy spanning over 25 years, she brings a wealth of knowledge and a distinctive viewpoint.

Her unwavering commitment to championing community pharmacy and empowering female pharmacists resonates deeply with the organisation's core values and its forward-looking vision.

With her background in leadership and entrepreneurial roles within the pharmacy profession, Sehar Shahid offers invaluable insights and a passion for driving positive change. A qualified independent pharmacist prescriber, consultant, and the director of 24 HR Pharmacy, her commitment to fostering inclusion and empowering future generations of female leaders exemplifies the NPA's ethos of inspiring and supporting women in pharmacy.

Whereas, the latest member, Aisling O’Brien, director of O'Brien’s chemists Ltd, brings extensive experience and a deep understanding of community pharmacy to the board. With a career spanning 25 years and a proven track record of leadership within the pharmaceutical sector, Aisling's appointment reinforces the NPA's commitment to supporting women in leadership roles.

Speaking on the appointments, NPA Chair Nick Kaye expressed his delight in welcoming Aisling to the board, highlighting her expertise and dedication to the sector: “We are delighted to welcome Aisling to the NPA board. She brings with her bags of relevant experience and a passion for community pharmacy. I know she will be an effective advocate for the NPA and the sector at large.”

With these appointments, the NPA reinforces its position as a leading advocate for diversity, inclusion, and excellence within the pharmacy sector, setting a precedent for other organisations to follow suit in embracing representative leadership.

More For You

Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less